|
|||||
       |
Biocartis, a diagnostic systems company in Lausanne, Switzerland says it completed raising €71 million (US$100 million) in series C equity funds, led by the company’s senior management and backed by current and new investors, as well as industrial collaborators. Series C financing is the third round of equity funding after start-up. Biocartis develops compact molecular . . . → Read More: Diagnostics Developer Secures $100M Series C Financing  Comments are closed  Finance  biomedical, computer science, engineering, equity, Europe, genomics, investment, life sciences, medical device, venture capital (fnal.gov) CytoDyn Inc., a biotechnology company in Lutz, Florida, has agreed to support research by Spripps Research Institute scientist John Elder on the company’s treatment for feline immunodeficiency virus (FIV). Elder is a professor in Scripps’s Department of Immunology and Microbial Science in La Jolla, California. Under the agreement CytoDyn’s subsidiary, CytoDyn Veterinary . . . → Read More: Scripps, Biotech to Partner on Feline Virus Research Comments are closed Joint ventures/collaborations biomedical, biotechnology, grant, HIV, life sciences, patent, pharmaceuticals (Incyte Corp.) The Food and Drug Administration today approved the drug ruxolitinib, to treat the bone marrow disease myelofibrosis, for marketing in the U.S. Ruxolitinib is marketed under the brand name Jakafi by Incyte Corporation, a biotechnology company in Wilmington, Delaware. Jakafi is a pill taken two times a day to inhibit enzymes . . . → Read More: Treatment for Rare Bone Marrow Disease Gains FDA Approval Comments are closed Regulations biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals Red blood cell (science360.gov) Researchers at King’s College London have developed a process to screen patients for genetic and acquired clinical conditions from a single dried blood spot. The college also started today a spin-off diagnostics company providing services using this method. The test, developed by a team from King’s College and clinician . . . → Read More: Dried Blood Test Developed, Spin-Off Company Formed 2 comments - (Comments are closed) Intellectual property, New products biomedical, engineering, entrepreneurs, Europe, licensing, life sciences, medical device, U.K., university t:slim Insulin Delivery System (Tandem Diabetes Care) Tandem Diabetes Care Inc. in San Diego says the Food and Drug Administration has cleared the company’s insulin pump system for marketing in the U.S. The t:slim Insulin Delivery System, as it’s called, is one of the first insulin pumps to be cleared under the FDA’s . . . → Read More: FDA Approves Touch-Screen Insulin Pump System One comment - (Comments are closed) Regulations biomedical, computer science, engineering, FDA, life sciences, medical device, software (Research.gov) Allena Pharmaceuticals Inc. in Newton, Massachusetts, a biotechnology start-up company, says it has secured $15 million in Series A venture capital financing, the first round of funding after seed capital. The company was founded by Alexey Margolin and Robert Gallotto, former executives at Alnara Pharmaceuticals that was acquired by Eli Lilly and . . . → Read More: Biotech Start-Up Lands $15M Series A Round One comment - (Comments are closed) Finance biomedical, biotechnology, entrepreneurs, equity, investment, pharmaceuticals, venture capital Engineering researchers at University of Arkansas in Fayetteville are developing an anti-icing system that could make airport runways safer and less expensive to maintain during winter months. The team led by civil engineering professor Ernie Heymsfield are now testing components of the system at the university’s Engineering Research Center in south Fayetteville. The approach uses . . . → Read More: Airport Runway De-Icing System Developed with Solar Panels 4 comments - (Comments are closed) New products energy, engineering, physical sciences, solar, university (Intel Corp.) Computer engineers at North Carolina State University in Raleigh are developing a three-dimensional central processing unit (CPU) that aims to increase energy efficiency by 15 percent. The project, funded by a $1.5 million grant from the Intel Corporation, is led by Paul Franzon, a professor of electrical and computer engineering at . . . → Read More: Intel Corp. to Fund 3D Computer Processing Unit Development Comments are closed Finance, New products computer science, energy, engineering, grant, manufacturing, physical sciences, semiconductors, university Midatech Ltd. in Oxford, U.K. says it has received approval from regulatory authorities in Switzerland for a clinical trial of the company’s insulin-coated gold nanoparticles. The company says it is the first test in humans of therapies based on solid nanoparticles. Midatech says the trial will test the safety of insulin-coated gold nanoparticles when applied . . . → Read More: Trial of Insulin-Coated Gold Nanoparticles Approved One comment - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, Europe, life sciences, nanotechnology, pharmaceuticals Human embryonic stem cell colony (Clay Glennon/Univ of Wisconsin-Madison, NIGMS) Geron Corporation, a biotechnology company in Menlo Park, California, says it has discontinued its development of therapies based on human embryonic stem cells to focus on cancer drugs. The immediate results of its decision are to end a clinical trial of its stem . . . → Read More: Geron Halts Embryonic Stem Cell Research, Clinical Trial Comments are closed Business conditions, Hiring/layoffs biomedical, biotechnology, cancer, clinical trials, economics, FDA, grant, life sciences, pharmaceuticals, stem cells |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.